PCVX insider reports $566,913 in planned share sales

PCVX insider reported planned sales of company common stock.

Rhea-AI Filing Summary

PCVX insider reported planned sales of company common stock. The filing lists two sale notices: 7,395 shares for $435,438.31 dated 03/10/2026 and 2,250 shares for $131,475.60 dated 04/01/2026, totaling $566,913.91. The filing also lists recent issuer vesting events (RSU and ESPP) with specified share counts and vesting dates.

Key Figures

Shares sold (first notice): 7,395 shares Proceeds (first notice): $435,438.31 Shares sold (second notice): 2,250 shares +5 more

8 metrics

Shares sold (first notice) 7,395 shares sale dated 03/10/2026

Proceeds (first notice) $435,438.31 amount shown for 03/10/2026 sale

Shares sold (second notice) 2,250 shares sale dated 04/01/2026

Proceeds (second notice) $131,475.60 amount shown for 04/01/2026 sale

Total proceeds (sum of notices) $566,913.91 aggregate of listed sale amounts

RSU vest (Mar 2, 2025) 743 shares RSU Vest dated 03/02/2025

ESPP (May 16, 2025) 329 shares ESPP dated 05/16/2025

RSU vest (Aug 31, 2025) 1,178 shares RSU Vest dated 08/31/2025

Key Terms

Form 144, RSU Vest, ESPP, Issuer

4 terms

Form 144 regulatory

"Securities Sold During The Past 3 Months — James Wassil entries"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

RSU Vest financial

"03/02/2025 | RSU Vest | Issuer | 743"

ESPP financial

"05/16/2025 | ESPP | Issuer | 329"

An Employee Stock Purchase Plan (ESPP) is a company program that lets employees buy the company’s shares at a reduced price, usually by setting aside a small portion of their pay over time. It matters to investors because it encourages employees to own part of the business—like giving staff a discounted membership— which can boost commitment and performance, while also potentially increasing the number of shares available and affecting shareholder value.

Issuer regulatory

"RSU Vest | Issuer and ESPP | Issuer entries"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the PCVX Form 144 report show?

It reported planned sales totaling $566,913.91 across two notices. The filing lists 7,395 shares for $435,438.31 (03/10/2026) and 2,250 shares for $131,475.60 (04/01/2026). It also records issuer vesting events (RSU and ESPP) with dates and share counts.

Who is the reporting person on the PCVX filing?

The filing identifies James Wassil as the reporting person. The address shown is 825 Industrial Road, Ste. 300, San Carlos, CA. The sale notices and amounts are associated with that reporting person in the Form 144 excerpt.

What recent equity vesting events are listed in the PCVX excerpt?

The excerpt lists RSU and ESPP vesting events with share counts and dates. Examples: RSU vest on 03/02/2025 for 743 shares, ESPP on 05/16/2025 for 329 shares, and RSU vest on 08/31/2025 for 1,178 shares.

Are the dollar amounts in the PCVX filing proceeds or estimates?

The filing shows aggregate dollar figures tied to the listed sales. It records $435,438.31 and $131,475.60 linked to the specific sale dates and share counts; the excerpt does not state additional use or allocation of proceeds.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/01/2026 - 04:17 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001813798
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Vaxcyte, Inc.
SEC File Number	001-39323
Address of Issuer	825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CALIFORNIA 94070
Phone	650-837-0111
Name of Person for Whose Account the Securities are To Be Sold	Wassil Jim
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. 11 Madison Ave 4th Floor New York NY 10010	2250	128835.00	143920361	05/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/02/2025	RSU Vest	Issuer			743	03/02/2025	N/A
Common	05/16/2025	ESPP	Issuer			329	05/16/2025	N/A
Common	08/31/2025	RSU Vest	Issuer			1178	08/31/2025	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
James Wassil 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070	Common	03/10/2026	7395	435438.31
James Wassil 825 INDUSTRIAL ROAD STE. 300 SAN CARLOS CA 94070	Common	04/01/2026	2250	131475.60

144: Remarks and Signature

Remarks
Date of Notice	05/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/09/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for James Wassil
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)